Page last updated: 2024-08-23

pravastatin and Viremia

pravastatin has been researched along with Viremia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carter, D; Chandraker, A; Gabardi, S; Kim, M; Klasek, R; Mackenzie, MR; Ramasamy, S; Tan, CS	1
Buss, NE; Gazzard, BG; Moyle, GJ	1
Freed, EO; Grubb, JR; Maldarelli, F; Masur, H; Ono, A; Sklar, PA; Voell, J; Witek, J	1

Trials

1 trial(s) available for pravastatin and Viremia

Article	Year
Pravastatin does not alter protease inhibitor exposure or virologic efficacy during a 24-week period of therapy. Journal of acquired immune deficiency syndromes (1999), 2002, Aug-01, Volume: 30, Issue:4 Topics: Anticholesteremic Agents; Antiretroviral Therapy, Highly Active; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Male; Pravastatin; Viremia	2002

Other Studies

2 other study(ies) available for pravastatin and Viremia

Article	Year
Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:4 Topics: Adult; Aged; BK Virus; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Polyomavirus Infections; Postoperative Complications; Pravastatin; Treatment Outcome; Tumor Virus Infections; Viremia	2015
Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy. AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10 Topics: Adult; Anti-HIV Agents; Anticholesteremic Agents; Cholesterol; Female; HIV Infections; Humans; Male; Pravastatin; Viral Load; Viremia	2005

Article

Year

Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.

Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:4

Topics: Adult; Aged; BK Virus; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Polyomavirus Infections; Postoperative Complications; Pravastatin; Treatment Outcome; Tumor Virus Infections; Viremia

2015

Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy.

AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10

Topics: Adult; Anti-HIV Agents; Anticholesteremic Agents; Cholesterol; Female; HIV Infections; Humans; Male; Pravastatin; Viral Load; Viremia

2005